- Home
- BANC vs BEAM Comparison
BANC vs BEAM Comparison
Compare BANC & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANC
- BEAM
- Stock Information
- Founded
- BANC 1941
- BEAM 2017
- Country
- BANC United States
- BEAM United States
- Employees
- BANC N/A
- BEAM N/A
- Industry
- BANC Major Banks
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BANC Finance
- BEAM Health Care
- Exchange
- BANC Nasdaq
- BEAM Nasdaq
- Market Cap
- BANC 2.8B
- BEAM 2.3B
- IPO Year
- BANC N/A
- BEAM 2020
- Fundamental
- Price
- BANC $14.99
- BEAM $30.43
- Analyst Decision
- BANC Buy
- BEAM Buy
- Analyst Count
- BANC 13
- BEAM 10
- Target Price
- BANC $18.08
- BEAM $48.75
- AVG Volume (30 Days)
- BANC 1.7M
- BEAM 1.2M
- Earning Date
- BANC 01-23-2025
- BEAM 03-04-2025
- Dividend Yield
- BANC 2.66%
- BEAM N/A
- EPS Growth
- BANC N/A
- BEAM N/A
- EPS
- BANC 0.52
- BEAM N/A
- Revenue
- BANC $960,394,000.00
- BEAM $349,643,000.00
- Revenue This Year
- BANC N/A
- BEAM N/A
- Revenue Next Year
- BANC $10.14
- BEAM $14.62
- P/E Ratio
- BANC $29.09
- BEAM N/A
- Revenue Growth
- BANC 289.07
- BEAM 328.73
- 52 Week Low
- BANC $11.88
- BEAM $20.84
- 52 Week High
- BANC $18.08
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- BANC 36.73
- BEAM 57.12
- Support Level
- BANC $15.50
- BEAM $25.35
- Resistance Level
- BANC $16.00
- BEAM $35.25
- Average True Range (ATR)
- BANC 0.44
- BEAM 2.10
- MACD
- BANC -0.11
- BEAM 0.56
- Stochastic Oscillator
- BANC 2.92
- BEAM 55.88
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. The company's services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.